Bone marrow scintigraphy as a useful method for estimating the physiological status of bone marrow and spleen in polycythaemia vera

Leukemia and Lymphoma

Volumn 22, Issue SUPPL. 1, 1996, Pages 105-110

  Rain, J D ^a   Najean, Y ^a   Billotey, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Bone marrow scintigraphy; Polycythaemia vera; Post polycythaemia myeloid metaplasia

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TRANSFERRIN IN 111;

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW SCINTISCANNING; DIAGNOSTIC VALUE; DRUG UPTAKE; HUMAN; MAJOR CLINICAL STUDY; MYELOID METAPLASIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLEEN;

EID: 0029958189     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609074367     Document Type: Article

References (25)

1. Najean, Y., Arrago, J. P., Rain, J. D. and Dresch, C. (1984) The "Spent" phase of polycythaemia vera : hypersplenism in the absence of myelofibrosis. Br. J. Haematol., 56, 163-170.
2. Najean, Y., Caccione, R., Castro-Malaspina, H. and Dresch, C. (1978) Erythro kinetic studies in myelofibrosis : their significance for prognosis. Br. J. Haematol., 40, 205-217.
3. Berlin, N. I. (1975) Diagnosis and classification of the polycythemias. Semin. Hamatol., 12, 339-351.
4. Mac Neil, B., Holman, B. H., Button, L. N. and Rosenthal, D. S. (1974) Use of indium chloride scintigraphys in patients with myelofibrosis. J. Nucl. Med., 15, 647-651.
5. Najean, Y., Legrand, M., Poirier, O., Senechal, A. and Arrago, J.P. (1990) Clinical significance of serum procollagen III in chronic myeloproliferative disorders. Eur. J. Haematol., 45, 239-243.
6. Parmentier, C., Therain, F., Charbord, P., Aubert, B. and Morardet, N. (1977) Comparative study of 111 In and 59 fe bone marrow scanning. Eur. J. Nucl. Med., 2, 89-92.
7. Chaudhuri, T. K., Ehrhardt, J. C., De Gowin, R. L. and Christie, J. H. (1974) 59 Fe Whole body scanning. J. Nucl. Med., 15, 667-673.
8. Ronai, P., Winchell, H. S., Auger, H. O. and Lawrence, J. H. (1969) Whole body scanning of 59 Fe for evaluating body distribution of red cells and hepatic deposition of iron. J. Nucl. Med., 10, 469-174.
9. Ferrant, A., Rodhain, J., Cauwe, F., Beckers, C., Michaux, J. L., Verwilgren, R. and Sokal, G. (1982) Assessment of bone marrow and splenic erythropoiesis in myelofibrosis. Scand. J. Haematol., 29, 373-380.
10. Beamish, M. R. and Brown, E. B. (1974) The metabolism of transferrin-bound 111 In and 59 Fe in the rat. Blood, 43, 693-701.
11. Mc Intyre, P. A., Larson, B. M., Eikman, E. A., Colman, M., Scheffel, V. and Hodkinson, B. A. (1974) Comparison of the metabolism of iron labeled-transferrin (Fe-Tf) and Indium-labeled transferrin (In-Tf) by the erythopoietic marrow. J. Nucl. Med., 15, 856-862.
12. Merrick, M. V., Gordon-Smith, E. C., Lavender, J. P. and Szur, L. (1975) A comparison of 111 In with 59 Fe and 99 mTc-Sulfur colloid for bone marrow scanning. J. Nucl. Med., 16, 66-68.
13. Arrago, J. P., Rain, J. D., Vigneron, N., Poirier, O., Chomienne, C., D'Agay, M. F. and Najean, Y. (1985) Diagnostic value of bone marrow imaging with 111 Indium-Tranferrin and 99m Technetium-Colloïds in myelofibrosis. Am. J. Hematol., 18, 275-282.
14. Rain, J. D. and Najean, Y. (1993) Bone marrow scintigraphy in myelofibrosis. Nouv. Rev. Fr. Hematol., 35, 101-102.
15. Sayle, B. A., Helmer, R. E., Birdsong, B. A., Balachandran, S. and Gardner, F. H. (1982) Bone marrow imaging with Indium 111 chloride in aplastic anemia and myelofibrosis: concise communication. J. Nucl. Med., 121-125.
16. Datz, F. L. and Taylor, A. (1985) The clinical use of radionuclide bone marrow imaging. Semin. Nucl. Med., 15, 239-259.
17. Harnsberger, H. R., Datz, F. L. and Knochel, J. Q. (1982) Failure to detect extra medullary hematopoiesis during bone marrow imaging with Indium 111 or Technetium 99 m Sulfur colloid. J. Nucl. Med., 23, 589-590.
18. Vieras, F. (1975) Splenic uptake of In 111. J. Nucl. Med., 16, 1205-1206.
19. Staub, R. T. and Gaston, E. (1973) In 111 Chloride distribution and kinetics in hematologic disease. J. Nucl. Med., 14, 456-457.
20. Ward, H. P. and Block, M. H. (1971) The natural history of agnogenic myeloid metaplasia (A.M.M) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medecine, 50, 357-420.
21. Van Dyke, B., Shkurkin, C., Price, D., Yano, Y. and Auger, H. O. (1967) Differences in distribution of erythropoietic and reticulo endothelial marrow in hematological disease. Blood, 30, 364-374.
22. Ferrant, A., Rodhain, J. and Leners, N. (1986) Quantitative assessment of erythropoiesis in bone marrow expansion areas using 52 Fe. Br. J. Haematol., 62, 247-255.
23. Rain, J. D., Najean, Y. (1993) Scintigraphie medullaire. Apport pour le diagnostic et le pronostic des myelofibroses. Presse Médicale, 22, 855-863.
24. Schlageter, M. H., Toubert, M. E., Podgorniak, M. P. and Najean, Y. (1990) Radio-immuno assay of erythropoietin: analytical performance and clinical use in hematology. Clin. Chem., 36, 1731-1735.
25. Barosi, G., Ambrosetti, A., Buratti, A., Finelli, C., Liberato, N. L., Quaglini, S., Ricetti, M. M., Visani, G., Tura, S. and Ascari, E. (1993) Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia, 7, 200-206.